Solventum Co. (NYSE:SOLV) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio lowered its position in Solventum Co. (NYSE:SOLV) by 16.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 74,425 shares of the company’s stock after selling 14,356 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Solventum were worth $5,189,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Y Intercept Hong Kong Ltd purchased a new position in shares of Solventum in the 3rd quarter worth about $1,149,000. MML Investors Services LLC raised its holdings in Solventum by 3.2% in the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock valued at $373,000 after buying an additional 168 shares during the period. Orion Portfolio Solutions LLC acquired a new position in Solventum during the third quarter valued at approximately $1,316,000. XTX Topco Ltd purchased a new stake in Solventum during the third quarter worth approximately $416,000. Finally, EP Wealth Advisors LLC acquired a new stake in shares of Solventum in the third quarter worth $355,000.

Solventum Price Performance

Shares of SOLV opened at $69.56 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The business’s 50 day moving average is $70.91 and its two-hundred day moving average is $63.22. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05.

Analyst Ratings Changes

Several research firms recently weighed in on SOLV. Mizuho initiated coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Wolfe Research began coverage on Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Finally, Stifel Nicolaus began coverage on shares of Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $68.29.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.